Activation of SPARC expression in reactive stroma associated with human epithelial ovarian cancer

T J Brown1, P A Shaw, X Karp

  • 1Department of Obstetrics and Gynecology, University of Toronto, Ontario, Canada.

Gynecologic Oncology
|September 30, 1999
PubMed
Abstract

Insights

Secreted protein, acidic, rich in cysteine (SPARC) is upregulated in the stroma of invasive ovarian cancer. SPARC may be internalized by cancer cells, influencing their behavior.

Area of Science:

  • Oncology
  • Molecular Biology
  • Gynecologic Pathology

Background:

  • Secreted protein, acidic, rich in cysteine (SPARC) is a glycoprotein implicated in tumor progression.
  • SPARC is typically downregulated in ovarian carcinomas, suggesting a tumor suppressor role.
  • Understanding SPARC expression changes during ovarian malignant transformation is crucial.

Purpose of the Study:

  • To investigate the distribution of SPARC mRNA and protein in malignant and nonmalignant ovarian tissues.
  • To clarify the role of SPARC in ovarian cancer development and invasiveness.

Main Methods:

  • In situ hybridization and immunohistochemistry were used to examine SPARC expression.
  • Patient specimens included 24 invasive ovarian cancers, 5 tumors of low malignant potential (LMP), and 8 nonmalignant ovaries.

Main Results:

  • SPARC mRNA and protein were detected in specific cells of nonmalignant ovaries.
  • Invasive ovarian cancers showed high SPARC mRNA and protein expression in the tumor stroma, especially at the invasive front.
  • SPARC protein was found in cancer cells, despite absent mRNA, suggesting internalization.

Conclusions:

  • SPARC is upregulated in the reactive stroma of invasive ovarian cancer.
  • Stromal SPARC may be internalized by ovarian cancer cells, potentially influencing intracellular functions.

Related Concept Videos

The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...